Regulatory Information
GSK CONSUMER HEALTHCARE SINGAPORE PTE. LTD.
GSK CONSUMER HEALTHCARE SINGAPORE PTE. LTD.
Therapeutic
General Sale List
Formulation Information
GEL
**DOSAGE / METHOD OF USE** **How is LAMISIL used?** Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. It is important to use **_LAMISIL_** dermgel correctly. Follow the instructions carefully. If you have **a fungal nail infection** (fungus inside and under the nail), with discoloration of the nails and change in nail texture (thick, flaky), you should see your doctor because _**LAMISIL**_ dermgel is NOT appropriate for this type of infection. Be aware that in rare case the underlying fungal infection may be aggravated. _**Lamisil**_ tablets, available on prescription only, should be used to treat nail fungus. For use on the skin. _**Directions for use:**_ - Clean and dry the affected skin and surrounding areas, and wash your hands. - Unscrew the cap, and if using for the first time, use the point in the cap to pierce the top of the tube, then gently squeeze the tube. - Apply enough gel to put a thin layer on the affected skin and surrounding areas. - Rub in gently. - Replace the cap on the tube. - Wash your hands so that you do not spread the infection on to yourself or on to others. If you are treating an infection in folded areas of your body you can cover the treated area with a gauze strip, especially at night. If you do, use a fresh, clean gauze strip each time you apply the dermgel. _**Duration of normal treatment**_ Adults: Ring worm, jock-itch, athlete’s foot or other superficial skin mycoses: Apply once a day for 1 week. Pityriasis vesicolor: apply once a day for 1 week. Use the gel for the recommended treatment period even if the infection seems to be better after a few days. Infections usually appear to improve within a few days, but may reappear if the cream is not applied regularly or is stopped too early. The gel should start to improve your skin condition in a few days. The gel will continue to work even after you have completed the treatment. If you have not noticed any signs of improvement within 2 weeks of first starting treatment, please see your doctor or pharmacist who will advise you. _**If you use more LAMISIL dermgel than you should**_ If you or someone else accidentally swallows some _**LAMISIL**_ dermgel, please tell your doctor who will advise you on what to do. Should a larger amount of Lamisil Dermgel be inadvertently ingested, adverse effects similar to those observed with an overdosage of Lamisil tablets are to be expected. These include headache, nausea, epigastric pain and dizziness. _**If you forget to use LAMISIL dermgel**_ If you forget an application of the gel, apply it as soon as possible and then carry on as normal. If you only remember at the time of the next application, just apply the usual amount and then carry on as normal. Do not take a double dose to make up for a forgotten dose.
TOPICAL
Medical Information
_**PROPERTIES / THERAPEUTIC USE**_ **What is LAMISIL and when is it used?** Lamisil dermgel is a medicine (antifungal agent) intended for treatment of skin infections caused by fungi (mycoses) such as ring worm, jock-itch, athlete’s foot or other superficial mycoses of the skin and pityriasis versicolor. Lamisil dermgel is available without prescription for you to treat the following skin infections without a doctor’s help (nevertheless you need to use it carefully to get the best results from it). _**LAMISIL**_ dermgel rapidly suppresses symptoms such as itching, desquamation (scaling) and red blotches.
**CONTRAINDICATIONS** **When should LAMISIL not be used?** Do not use this product if you are allergic (hypersensitive) to terbinafine base or any of the other ingredients of _**LAMISIL**_ dermgel. _**LAMISIL**_ dermgel is not recommended for use in children and adolescents below 18 years of age due to insufficient data on safety and efficacy.
D01AE15
terbinafine
Manufacturer Information
gsk consumer healthcare singapore pte. ltd.
GSK Consumer Healthcare SARL
NOVARTIS PHARMA PRODUKTIONS GMBH
Active Ingredients
Documents
Patient Information Leaflets
Lamisil Dermgel 1% PIL.pdf
Approved: April 17, 2020